Effects of a high fat diet on intestinal microbiota and gastrointestinal diseases

World Journal of Gastroenterology

Volumn 22, Issue 40, 2016, Pages 8905-8909

  Zhang, Mei ^a   Yang, Xiao Jiao ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Gastrointestinal diseases; High fat diet; Intestinal microbiota

Indexed keywords

PROBIOTIC AGENT;

BACTERIAL COLONIZATION; BACTEROIDETES; COLORECTAL CANCER; DISEASE ASSOCIATION; DYSBIOSIS; FAT INTAKE; FIRMICUTES; GASTROINTESTINAL DISEASE; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; IRRITABLE COLON; LIPID DIET; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MOLLICUTES; NONALCOHOLIC FATTY LIVER; NONHUMAN; REVIEW; RISK FACTOR; SPECIES COMPOSITION; ANIMAL; MICROBIOLOGY;

ANIMALS; DIET, HIGH-FAT; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; HUMANS;

EID: 84992702727     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i40.8905     Document Type: Review

References (38)

1. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012; 489: 242-249 [PMID: 22972297 DOI: 10.1038/nature11552]
2. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science 2005; 308: 1635-1638 [PMID: 15831718 DOI: 10.1126/science.1110591]
3. Palmer C, Bik EM, DiGiutio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5: e177 [PMID: 17594176 DOI: 10.1371/journal.pbio.0050177]
4. Mariat D, Firmesse O, Levenez F, GuimarǍes V, Sokol H, Doré J, Corthier G, Furet JP. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 2009; 9: 123 [PMID: 19508720 DOI: 10.1186/1471-2180-9-123]
5. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559-563 [PMID: 24336217 DOI: 10.1038/nature12820]
6. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, Knight R, Ahima RS, Bushman F, Wu GD. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009; 137: 1716-1724.e1-2 [PMID: 19706296 DOI: 10.1053/j.gastro.2009.08.042]
7. de Wit N, Derrien M, Bosch-Vermeulen H, Oosterink E, Keshtkar S, Duval C, de Vogel-van den Bosch J, Kleerebezem M, Müller M, van der Meer R. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am J Physiol Gastrointest Liver Physiol 2012; 303: G589-G599 [PMID: 22700822 DOI: 10.1152/ajpgi.00488.2011]
8. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 2009; 1: 6ra14 [PMID: 20368178 DOI: 10.1126/scitranslmed.3000322]
9. Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, Mao Y, Zhang X, Pang X, Wei C, Zhao G, Chen Y, Zhao L. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 2010; 4: 232-241 [PMID: 19865183 DOI: 10.1038/ismej.2009.112]
10. Liu XJ, Chen QS, Yan YL. Effect of high-fat diet on intestinal flora in mice. Food Science 2011; 32: 306-311
11. Cao HF, Zhang JC, Wang F, Xu J, Xu HY. Intake of a high-fat diet alters intestinal flora in male SD rats. Zhongguo Weishengtaixue Zazhi 2012; 24: 102-108
12. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010; 107: 14691-14696 [PMID: 20679230 DOI: 10.1073/pnas.1005963107]
13. DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol 2011; 8: 523-531 [PMID: 21844910 DOI: 10.1038/nrgastro.2011.133]
14. Fyderek K, Strus M, Kowalska-Duplaga K, Gosiewski T, Wedrychowicz A, Jedynak-Wasowicz U, Sladek M, Pieczarkowski S, Adamski P, Kochan P, Heczko PB. Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease. World J Gastroenterol 2009; 15: 5287-5294 [PMID: 19908336 doi: 10.3748/wjg.15.5287]
15. Walker AW, Sanderson JD, Churcher C, Parkes GC, Hudspith BN, Rayment N, Brostoff J, Parkhill J, Dougan G, Petrovska L. High-throughput clone library analysis of the mncosa associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Mierobiol 2011; 1: 7 [DOI: 10.1186/1471-2180-11-7]
16. Noor SO, Ridgway K, Scovell L, Kemsley EK, Lund EK, Jamieson C, Johnson IT, Narbad A. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol 2010; 10: 134 [PMID: 21073731 DOI: 10.118 6/1471-230X-10-134]
17. Cary VA, Boullata J. What is the evidence for the use of probiotics in the treatment of inflammatory bowel disease? J Clin Nurs 2010; 19: 904-916 [PMID: 20492035 DOI: 10.1111/j.1365-2702.2009.03123.x]
18. Whelan K, Quigley EM. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 2013; 29: 184-189 [PMID: 23286925 DOI: 10.1097/MOG.0b013e32835d7bba]
19. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-1988 [PMID: 19457422]
20. Chassard C, Dapoigny M, Scott KP, Crouzet L, Del'homme C, Marquet P, Martin JC, Pickering G, Ardid D, Eschalier A, Dubray C, Flint HJ, Bernalier-Donadille A. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther 2012; 35: 828-838 [PMID: 22315951 DOI: 10.1111/j.1365-2036.2012.05007.x]
21. Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2012; 24: 521-530, e248 [PMID: 22339879 DOI: 10.1111/j.1365-2982.2012.01891.x]
22. Parkes GC, Brostoff J, Whelan K, Sanderson JD. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment. Am J Gastroenterol 2008; 103: 1557-1567 [PMID: 18513268 DOI: 10.1111/j.1572-0241.2008.01869.x]
23. Ohman L, Simrén M. Intestinal microbiota and its role in irritable bowel syndrome (IBS). Curr Gastroenterol Rep 2013; 15: 323 [PMID: 23580243 DOI: 10.1007/s11894-013-0323-7]
24. Candela M, Guidotti M, Fabbri A, Brigidi P, Franceschi C, Fiorentini C. Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer. Crit Rev Microbiol 2011; 37: 1-14 [PMID: 20874522 DOI: 10.3109/1040841X.2010.501760]
25. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J, Furet JP. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011; 6: e16393 [PMID: 21297998 DOI: 10.1371/journal.pone.0016393]
26. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, Huttenhower C, Garrett WS, Meyerson M. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012; 22: 292-298 [PMID: 22009990 DOI: 10.1101/gr.126573.111]
27. Zackular JP, Baxter NT, Iverson KD, Sadler WD, Petrosino JF, Chenb GY, Schlossa PD. The gut microbiome modulates colon tumorigenesis. MBio 2013; 4: e00692-13 [PMID: 24194538 DOI: 10.1128/mBio.00692-13]
28. Sears CL, Pardoll DM. Perspective: alpha-bugs. their microbial partners, and the link to colon cancer. J Infect Dis 2011; 203: 306-311 [PMID: 21208921 DOI: 10.1093/jinfdis/jiq061]
29. Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driverpassenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 2012; 10: 575-582 [PMID: 22728587 DOI: 10.1038/nrmicro2819]
30. Liong MT. Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence. Int J Mol Sci 2008; 9: 854-863 [PMID: 19325789 DOI: 10.3390/ijms9050854]
31. Henao-Mejia J, Elinav E, Thaiss CA, Flavell RA. The intestinal microbiota in chronic liver disease. Adv Immunol 2013; 117: 73-97 [PMID: 23611286 DOI: 10.1016/B978-0-12-410524-9.00003-7]
32. Wang Y, Liu Y, Sidhu A, Ma Z, McClain C, Feng W. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcoholinduced intestinal permeability and liver injury. Am J Physiol Gastrointest Liver Physiol 2012; 303: G32-G41 [PMID: 22538402 DOI: 10.1080/07315724.2012.10720004]
33. Cope K, Risby T, Diehl AM. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 2000; 119: 1340-1347 [PMID: 11054393 DOI: 10.1053/gast.2000.19267]
34. Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001; 48: 206-211 [PMID: 11156641 DOI: 10.1136/gut.48.2.206]
35. Farhadi A, Gundlapalli S, Shaikh M, Frantzides C, Harrell L, Kwasny MM, Keshavarzian A. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int 2008; 28: 1026-1033 [PMID: 18397235 DOI: 10.1111/j.1478-3231.2008.01723.x]
36. Poritz LS, Garver KI, Tilberg AF, Koltun WA. Tumor necrosis factor alpha disrupts tight junction assembly. J Surg Res 2004; 116: 14-18 [PMID: 14732344 DOI: 10.1016/S0022-4804(03)00311-1]
37. Wu ZW, Ling ZX, Lu HF, Zuo J, Sheng JF, Zheng SS, Li LJ. Changes of gut bacteria and immune parameters in liver transplant recipients. Hepatobiliary Pancreat Dis Int 2012; 11: 40-50 [PMID: 22251469]
38. Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, Caviglia JM, Khiabanian H, Adeyemi A, Bataller R, Lefkowitch JH, Bower M, Friedman R, Sartor RB, Rabadan R, Schwabe RF. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 2012; 21: 504-516 [PMID: 22516259 DOI: 10.1016/j.ccr.2012.02.007]